AT

Andy Tran

Principal at Matrix Capital Management

Greater Boston

Overview

Work Experience

RT

ReCode Therapeutics

  • Board Observer and Investor

    2022 - Current

MT

Maze Therapeutics

  • Board Director and Lead Investor

    2022

G

GentiBio

  • Board Director and Lead Investor

    2021

MC

Matrix Capital Management Company, L.P.

  • Principal

    2021

    Leading investments in innovative biotechnology and healthcare companies. Focusing on long term investing out of a $8Bn AUM hedge fund to support companies through their entire life cycle (from early through crossover and public stages).

AH

Andreessen Horowitz

  • Investment Partner

    2018 - 2021

    Investing in early stage ventures at the frontier of biotech and engineering in therapeutics, diagnostics and tools. Seed and Series A Lead investments include Scribe Therapeutics, Insitro, Genesis Therapeutics, EQRx, Octant Biosciences, Tmunity, Nautilus, Earli, and several stealth seeds in the biotech space.

ST

Scribe Therapeutics

  • Investor and Board Observer

    2018 - 2021

A

Asimov

  • Board Observer

    2018 - 2021

i

insitro

  • Investor

    2018 - 2021

EQRx

  • Investor

    2018 - 2021

F

Freenome

  • Board Observer

    2018 - 2021

Education

Investments

Maze Therapeutics

Series Unknown

Total Funding: $380M

GentiBio

Series A

Total Funding: $160M

Relevant Websites